Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ
Christel Rousseaux, Bruno Lefebvre, Laurent Dubuquoy et al. · The Journal of Experimental Medicine · 2005
5-aminosalicylic acid (5-ASA) is an antiinflammatory drug widely used in the treatment of inflammatory bowel diseases. It is known to inhibit the production of cytokines and inflammatory mediators, but the mechanism underlying the intestinal effects of 5-ASA remains unknown. Based on the common activities of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands and 5-ASA, we hypothesized that this nuclear receptor mediates 5-ASA therapeutic action. To test this possibility, colitis was induced in heterozygous PPAR-gamma(+/-) mice and their wild-type littermates, which were then treated with 5-ASA. 5-ASA treatment had a beneficial effect on colitis only in wild-type and not in heterozygous mice. In epithelial cells, 5-ASA increased PPAR-gamma expression, promoted its translocation from the cytoplasm to the nucleus, and induced a modification of its conformation permitting the recruitment of coactivators and the activation of a peroxisome-proliferator response element-driven gene. Validation of these results was obtained with organ cultures of human colonic biopsies. These data identify PPAR-gamma as a target of 5-ASA underlying antiinflammatory effects in the colon.
Cited by 526 works. doi:10.1084/jem.20041948 Open-access PDF
Authors
- Christel Rousseaux
- Bruno Lefebvre
- Laurent Dubuquoy
- Philippe Lefèbvre
- Olivier Romano
- Johan H. Auwerx
- Daniel METZGER
- Walter Wahli
- Béatrice Desvergne
- Gian Carlo Naccari
- Philippe Chavatte
- Amaury Farce
- Philippe Bulois
- Antoine Cortot
- Jean Frédéric Colombel
- Pierre Desreumaux
References
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
- TGF-β SIGNAL TRANSDUCTION
- The nuclear receptor superfamily: The second decade
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
- Validation of the general purpose tripos 5.2 force field
- PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
- Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ